Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W O Bechstein

Showing results (221-230 of 351) with videos related to

Pageof 36
Sort By:
Transplantation Proceedings|February 1, 1995
Recurrent hepatitis C infection after orthotopic liver transplantationM Knoop, W O Bechstein, G Blumhardt, et al.
Transplantation Proceedings|February 1, 1997
Pilot study: Carolina Rinse Solution improves graft function after orthotopic liver transplantation in humansS Bachmann, W O Bechstein, H Keck, et al.
Journal of Medical Virology|August 10, 1999
Occurrence of a novel DNA virus (TTV) infection in patients with liver diseases and its frequency in blood donorsT Berg, E Schreier, H G Heuft, et al.
Transplantation Proceedings|February 1, 1997
Cyclosporin new oral formulation for early oral immunosuppressive therapy in liver transplant recipientsM Winkler, G W Haller, K Oldhafer, et al.
Zeitschrift Fur Gastroenterologie|June 7, 2013
Self-expandable metal stent for malignant colonic obstruction: outcome in proximal vs. left sided tumor localizationA O Tal, M Friedrich-Rust, W O Bechstein, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
Bacterial and fungal colonization and infections using oral selective bowel decontamination in orthotopic liver transplantationsR Steffen, O Reinhartz, G Blumhardt, et al.
Transplantation|September 15, 1994
Long-term follow-up of hepatitis B virus-infected recipients after orthotopic liver transplantationV König, U Hopf, P Neuhaus, et al.
Cancer|September 26, 1997
De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulinS Jonas, N Rayes, U Neumann, et al.
Transplantation|July 27, 1994
Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506A R Mueller, K P Platz, W O Bechstein, et al.
Transplantation Proceedings|April 1, 1996
Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantationW O Bechstein, P Neuhaus, P McMaster, et al.
Pageof 36

Showing results (221-230 of 351) with videos related to

Sort By:
Pageof 36
Transplantation Proceedings|February 1, 1995
Recurrent hepatitis C infection after orthotopic liver transplantationM Knoop, W O Bechstein, G Blumhardt, et al.
Transplantation Proceedings|February 1, 1997
Pilot study: Carolina Rinse Solution improves graft function after orthotopic liver transplantation in humansS Bachmann, W O Bechstein, H Keck, et al.
Journal of Medical Virology|August 10, 1999
Occurrence of a novel DNA virus (TTV) infection in patients with liver diseases and its frequency in blood donorsT Berg, E Schreier, H G Heuft, et al.
Transplantation Proceedings|February 1, 1997
Cyclosporin new oral formulation for early oral immunosuppressive therapy in liver transplant recipientsM Winkler, G W Haller, K Oldhafer, et al.
Zeitschrift Fur Gastroenterologie|June 7, 2013
Self-expandable metal stent for malignant colonic obstruction: outcome in proximal vs. left sided tumor localizationA O Tal, M Friedrich-Rust, W O Bechstein, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1994
Bacterial and fungal colonization and infections using oral selective bowel decontamination in orthotopic liver transplantationsR Steffen, O Reinhartz, G Blumhardt, et al.
Transplantation|September 15, 1994
Long-term follow-up of hepatitis B virus-infected recipients after orthotopic liver transplantationV König, U Hopf, P Neuhaus, et al.
Cancer|September 26, 1997
De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulinS Jonas, N Rayes, U Neumann, et al.
Transplantation|July 27, 1994
Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506A R Mueller, K P Platz, W O Bechstein, et al.
Transplantation Proceedings|April 1, 1996
Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantationW O Bechstein, P Neuhaus, P McMaster, et al.
Pageof 36